The Star Ratings story from last October has been sitting in the background of every carrier conversation since. This edition puts it front and center — because the 2026 results are not a scorecard. They are a 2027 planning document.
Also in this edition: the UHC referral grace period was extended past April 30 with no new end date announced. Most agents who sent their May 1 explainers don't know that yet. And a brief, operational GLP-1 update — because July 1 is six weeks away and the calls are coming.
— The Axxess Strategy Team
1. The Star Ratings Reshuffle: What the 2026 Results Tell You About AEP 2027 Before Anyone Else Is Looking
Pull Quote "A plan's Star Rating today is not a quality certificate. It is a forward-looking revenue signal — and right now, that signal is telling you which carriers are about to get more aggressive and which ones are about to pull back."
The data
The Centers for Medicare & Medicaid Services (CMS) released the 2026 Medicare Advantage (MA) Star Ratings in October 2025. Thirty-four MA plans earned 5 stars — up sharply from 7 in 2025, though still below the 38 contracts that earned 5 stars in 2024. [Source: Healthcare Finance News, October 2025] Five plans dropped to 2 stars, compared to one in 2025. The average rating held essentially flat at 3.66, up from 3.65 in 2025. Approximately 64% of MA enrollees are in 4-star-or-higher plans.
Carrier-level results reveal the strategic picture beneath the averages. CVS (Aetna) leads large carriers with over 81% of members in 4-star-or-higher plans. UnitedHealthcare maintained approximately 77% of members in 4-star-or-higher contracts. Elevance improved from 40% to 53% of members in 4-star-or-higher plans after a key contract moved from 3.5 to 4.0 stars. Centene jumped from roughly 1% to 18% of members in 4-star-or-higher plans. [Source: Certifi, Healthcare Dive, October 2025]
Why this matters more than the headlines suggest
Star Ratings are not a quality story for agents. They are a money story — and the money flows in a specific direction.
Plans rated 4 stars or above receive Quality Bonus Payments (QBP) from CMS. Those bonus payments fund the supplemental benefits — dental, vision, OTC allowances, fitness memberships — that agents use to differentiate plans during the Annual Enrollment Period (AEP). Plans below 4 stars lose the QBP. They either cut benefits to protect margins, raise premiums, or both.
The 2026 results draw a sharp line. On one side: carriers with strong or improving Star Ratings who have the bonus revenue to maintain or enrich benefits heading into AEP 2027. On the other: carriers that fell below 4 stars whose 2027 benefit packages are already under pressure.
The Quiet Shift Plans that earned 5 stars for 2026 gain a structural enrollment advantage that most agents don't use: 5-star plans can enroll new members year-round, outside the Annual Enrollment Period. That window is open right now. The agents who know which 5-star plans operate in their service area and who have clients in deteriorating plans have a legitimate mid-year enrollment conversation available to them today — not in October.
Agents are not restricted to selling in their home state. If no 5-star plans operate in your current service area, this is the moment to explore licensure in a neighboring state — or any state where 5-star plans are active. Mid-year, outside AEP and OEP, is exactly when agents with multi-state flexibility find opportunities others miss.
Axxess Perspective: Read the Stars as an AEP 2027 positioning map
Before AEP prep begins in August, every agent should answer three questions from the 2026 Star data:
- Which plans in my service area dropped below 4 stars for 2026? Those plans face QBP losses, which means benefit compression or premium increases for 2027. The clients enrolled in those plans are the most likely switchers.
- Which carriers in my service area are on an upward trajectory? Elevance moving from 3.5 to 4.0 and Centene's jump from near-zero to 18% in 4-star-or-higher plans are meaningful signals. Rising-star carriers tend to invest bonus revenue in competitive benefits.
- Are any 5-star plans operating in my service area? If yes, mid-year enrollment is available now for eligible clients in deteriorating plans.
The agents who walk into AEP 2027 with a carrier-by-carrier Stars map of their service area will have a recommendation framework the agents who don't simply can't match.
2. The UHC Referral Grace Period Is Still Open. That's the Story.
The conventional view: UHC's referral enforcement started May 1. Agents have already sent their explainers. The hard part is over.
The contrarian view: The hard part hasn't started. And the agents who told clients enforcement was live may need to make a correction call.
What actually happened
On or around May 1, 2026, UHCprovider.com posted a quiet update to its referral requirements page: "We'll continue to defer adverse payment decisions related to referral requirements, extending the current grace period previously set to end April 30, 2026. We'll share additional details as updates are implemented, including advance notice before the grace period ends." [Source: UHCprovider.com, May 2026]
No new end date was announced. No press release. The referral requirement still exists — it was never eliminated. Enforcement of adverse payment decisions is still paused. But the financial consequence for missing a referral remains deferred.
Why this matters for your book
Most agents communicated the original April 30 deadline to their UnitedHealthcare HMO and POS clients. The enforcement date passed and nothing changed for clients. That creates a service dynamic agents need to manage.
From the Field "I had a client call me in early May confused because her specialist appointment went through fine without a referral. She thought I'd misinformed her. I had to explain that enforcement is paused — not that the rule is gone. That's a harder conversation than the original one." — Medicare agent, Midwest region (anonymized for compliance)
Axxess Perspective
Three actions before June 1:
- Monitor the UHCprovider.com referral requirements page directly. When UHC announces a new grace period end date, it will appear there first. Set a weekly calendar reminder.
- Send a brief update to every UHC HMO/POS client who received your original explainer. Two sentences: enforcement is still paused, no new date announced, you'll notify them when that changes.
- Document every client communication in your CRM. When enforcement does begin, documented communication trails demonstrate due diligence. The absence of them doesn't.
The referral requirement is not going away. The grace period will end. The agents who stay current will own the service call.
3. GLP-1 Coverage Goes Live July 1: Four Questions Before the Calls Start
The Medicare GLP-1 Bridge launches July 1, 2026. Eligible Medicare Part D beneficiaries will pay $50 per month flat for Wegovy, Zepbound (KwikPen only), or Foundayo — regardless of dosage. The $50 copay does not count toward the Part D deductible or the $2,100 annual out-of-pocket cap. Prior authorization goes through a central processor, not the client's plan.
The Quiet Shift Eligibility is assessed at the time glucagon-like peptide-1 (GLP-1) therapy was first initiated — not today. A client who started a GLP-1 in 2024 with a body mass index (BMI) of 37 and has since lost weight still qualifies if their provider attests to the historical BMI. Clients already on a GLP-1 who believe they no longer qualify because the drug worked may still be eligible. That's the conversation worth having before July 1.
Four questions every agent should be able to answer before the calls start:
- Which drugs are covered? Wegovy (all formulations), Zepbound (KwikPen only), Foundayo. Ozempic and Mounjaro are not covered — both carry diabetes indications, not weight-loss indications.
- What are the three eligibility pathways? BMI ≥ 35 (automatic); BMI ≥ 30 with heart failure, uncontrolled hypertension, or chronic kidney disease; BMI ≥ 27 with pre-diabetes, prior heart attack, prior stroke, or peripheral artery disease. [Source: CMS FAQ, May 2026]
- Does the client's plan type qualify? Standalone PDPs and MA-PD plans qualify. PACE organizations, private fee-for-service (PFFS) plans, and employer group waiver plans (EGWPs) do not.
- Who handles the prior authorization? A CMS central processor — not the client's plan.
- What should the client do next? The prior authorization process is initiated by the prescribing provider — not the client and not the agent. The client's next step is to contact their doctor and ask them to submit a prior authorization request through the CMS central processor. Agents should not contact CMS directly on the client's behalf. Your role is to confirm the client's plan type qualifies, confirm the drug is covered under the Bridge, and direct them back to their prescriber to initiate the PA.
Know these answers before your phone rings in July.
1. AEP 2027 Benefit Compression. Per HealthScape Advisors' 2026 MA executive survey, not one health plan leader surveyed expects richer benefits in 2027. Sixty-nine percent expect enrollment to remain flat or decline. The benefit compression of 2026 is a floor, not a correction — and agents who set client expectations now will have fewer difficult conversations in October. [Source: HealthScape Advisors, February 2026]
2. Network Mid-Year Disruption — July Cluster. NYP/UnitedHealthcare and BayCare/UnitedHealthcare contract disputes hit terminal deadlines in May and June. Mayo Clinic's Humana contract terminates July 1. The summer network reshuffle is calendared. Agents who ran provider audits in May are positioned. Agents who didn't should prioritize their highest-touch clients now.
3. GLP-1 Bridge End Date and AEP 2027. The Bridge runs through December 31, 2027. Clients who initiate GLP-1 therapy in July 2026 face an 18-month coverage window before the BALANCE Model is expected to take over. AEP 2027 plan selection will matter for clients who want continuity of access. That's a conversation that starts this fall.
Why we're watching this:
Six numbers that frame the Stars, referral, and GLP-1 landscape heading into Q3.
Stars & Carrier Strategy
- 34 plans earned 5 stars for 2026, up from 7 in 2025 → The top end is differentiating. 5-star plans can enroll year-round — a mid-year opportunity most agents aren't using.
- 5 plans dropped to 2 stars for 2026 → Plans below 4 stars lose Quality Bonus Payments. Benefit cuts or premium increases follow. Know which plans in your service area are affected.
- CVS (Aetna): 81% of members in 4-star plans or higher → Strongest quality positioning among large carriers. A story worth telling during renewals.
Compliance & Operations
- UHC referral grace period extended past April 30, no new end date → Enforcement is coming. The correction call window is still open. Don't wait.
- $50/month flat GLP-1 Bridge copay starting July 1 → Clients are about to find out. Whether they hear it from you first is a choice.
- PACE, PFFS, EGWP plan members do not qualify for the GLP-1 Bridge → Know your client's plan type before the call starts.
1. Map your service area's 2026 Star Ratings before August. Identify which plans dropped below 4 stars, which carriers are trending up, and whether any 5-star plans operate in your area. This is your AEP 2027 positioning map. Build it before summer network disruption adds complexity.
2. Send a two-sentence UHC referral update to every client who received your original May 1 explainer. Enforcement is still paused. No new end date has been announced. A brief proactive update removes client confusion and creates a documented service touchpoint. Do it before June 1.
3. Build a GLP-1 reference sheet and have it ready before July 1. Four questions, two minutes to answer. The clients who call in July will remember the agent who was already prepared.